Non-invasive detection of liver cirrhosis - the “Essen algorithm”

References

[1] Bellentani S,Saccoccio G.Prevalence of chronic liver disease in the general population of northern Italy: the Dionysos Study.Hepatology1994;20:1442-9

[2] Engelmann G,Teufel U.Limitations and opportunities of non-invasive liver stiffness measurement in children.World J Hepatol2017;9:409-17 PMCID:PMC5355763

[3] Wong GL-H.Non-invasive assessments for liver fibrosis: the crystal ball we long for.J Gastroenterol Hepatol2018;33:1009-15

[4] Association for the Study of the Liver. Electronic address: [e-mail], European Association for the Study of the Liver. EASL 2017 Clinical Practice Guidelines on the management of hepatitis B virus infection.J Hepatol2017;67:370-98

[5] Stasi C.Evolving strategies for liver fibrosis staging: non-invasive assessment.World J Gastroenterol2017;23:191-6 PMCID:PMC5236498

[6] Ellis EL.Clinical evidence for the regression of liver fibrosis.J Hepatol2012;56:1171-80

[7] Atwell TD,Hesley GK.Incidence of bleeding after 15,181 percutaneous biopsies and the role of aspirin.AJR Am J Roentgenol2010;194:784-9

[8] Rockey DC,Goodman ZD.Liver biopsy.Hepatology2009;49:1017-44

[9] Association for the Study of the Liver (EASL), European Association for the Study of Diabetes (EASD), European Association for the Study of Obesity (EASO). EASL-EASD-EASO Clinical Practice Guidelines for the management of non-alcoholic fatty liver disease.J Hepatol2016;64:1388-402

[10] Association for Study of Liver, Asociacion Latinoamericana para el Estudio del Higado. EASL-ALEH Clinical Practice Guidelines: non-invasive tests for evaluation of liver disease severity and prognosis.J Hepatol2015;63:237-64

[11] Peleg N,Sneh-Arbib O.AST to Platelet Ratio Index and fibrosis 4 calculator scores for non-invasive assessment of hepatic fibrosis in patients with non-alcoholic fatty liver disease.Dig Liver Dis2017;49:1133-8

[12] Wu HM,Wang Q.Performance of transient elastography in assessing liver fibrosis in patients with autoimmune hepatitis-primary biliary cholangitis overlap syndrome.World J Gastroenterol2018;24:737-43 PMCID:PMC5807676

[13] Karlas T,Sasso M.Impact of controlled attenuation parameter on detecting fibrosis using liver stiffness measurement.Aliment Pharmacol Ther2018;47:989-1000

[14] Guo L,Hu L.Transient Elastography (FibroScan) Performs Better Than Non-Invasive Markers in Assessing Liver Fibrosis and Cirrhosis in Autoimmune Hepatitis Patients.Med Sci Monit2017;23:5106-12 PMCID:PMC5669534

[15] Wilder J.The clinical utility of FibroScan(®) as a noninvasive diagnostic test for liver disease.Med Devices Auckl NZ2014;7:107-14 PMCID:PMC4014361

[16] Buechter M,Gerken G.Enzymatic liver function measured by LiMAx - a reliable diagnostic and prognostic tool in chronic liver disease.Sci Rep2019;9:13577 PMCID:PMC6753134

[17] Jara M,Valle E.Reliable assessment of liver function using LiMAx.J Surg Res2015;193:184-9

[18] Malinowski M,Lüttgert K.Enzymatic liver function capacity correlates with disease severity of patients with liver cirrhosis: a study with the LiMAx test.Dig Dis Sci2014;59:2983-91

[19] Desmet VJ,Hoofnagle JH.Classification of chronic hepatitis: diagnosis, grading and staging.Hepatology1994;19:1513-20

[20] Buechter M,Baba HA.Liver maximum capacity: a novel test to accurately diagnose different stages of liver fibrosis.Digestion2019;100:45-54